GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivesto AB (OSTO:VIVE) » Definitions » Total Operating Expense

Vivesto AB (OSTO:VIVE) Total Operating Expense : kr42.09 Mil (TTM As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Vivesto AB Total Operating Expense?

Vivesto AB's Total Operating Expense for the three months ended in Dec. 2024 was kr10.96 Mil. Vivesto AB's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was kr42.09 Mil.

Vivesto AB Total Operating Expense Historical Data

The historical data trend for Vivesto AB's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivesto AB Total Operating Expense Chart

Vivesto AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22 Dec23 Dec24
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 246.25 113.59 347.07 138.81 41.96

Vivesto AB Quarterly Data
Jan20 Apr20 Jul20 Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.83 9.31 11.02 10.81 10.96

Vivesto AB Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr42.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivesto AB Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Vivesto AB's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivesto AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivesto AB (OSTO:VIVE) » Definitions » Total Operating Expense
Comparable Companies
OSTO:TOL XSAT:ACUC OSTO:KLAR OSTO:NEWBRY OSTO:ERMA XSAT:ODI XSAT:PMED OSTO:NANEXA OSTO:GABA XSAT:DANCAN ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
OASMY:USA 0N4A:UK
Address
Gustav III:s Boulevard 46, 5th Floor, Solna, SWE, SE-169 73
Website
https://www.vivesto.com
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.